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Abstract: Orthopedic implants requiring osseointegration are often surface modified; however,
implants may shed these coatings and generate wear debris leading to complications. Titanium
nanotubes (TiNT), a new surface treatment, may promote osseointegration. In this study, in vitro
(rat marrow-derived bone marrow cell attachment and morphology) and in vivo (rat model of
intramedullary fixation) experiments characterized local and systemic responses of two TiNT surface
morphologies, aligned and trabecular, via animal and remote organ weight, metal ion, hematologic,
and nondecalcified histologic analyses. In vitro experiments showed total adherent cells on trabecular
and aligned TiNT surfaces were greater than control at 30 min and 4 h, and cells were smaller in
diameter and more eccentric. Control animals gained more weight, on average; however, no animals
met the institutional trigger for weight loss. No hematologic parameters (complete blood count with
differential) were significantly different for TiNT groups vs. control. Inductively coupled plasma mass
spectrometry (ICP-MS) showed greater aluminum levels in the lungs of the trabecular TiNT group
than in those of the controls. Histologic analysis demonstrated no inflammatory infiltrate, cytotoxic,
or necrotic conditions in proximity of K-wires. There were significantly fewer eosinophils/basophils
and neutrophils in the distal region of trabecular TiNT-implanted femora; and, in the midshaft of
aligned TiNT-implanted femora, there were significantly fewer foreign body giant/multinucleated
cells and neutrophils, indicating a decreased immune response in aligned TiNT-implanted femora
compared to controls.

Accepted: 15 February 2021
Published: 26 February 2021

Keywords: orthopedic; nanomedicine; nanomodified surfaces; animal model; immune response

Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-

1. Introduction

iations.

Titanium, both commercially pure and alloyed, has been used for decades in various
biologic environments, including orthopedic implant designs [1–4]. With a combination of
corrosion resistance, biocompatibility, mechanical properties approximating bone, and low
cost, titanium continues to be a common material for fracture plates and screws as well
as components requiring solid bone–implant fixation (e.g., knee arthroplasty tibial tray,
hip arthroplasty femoral stem) [1–4]. To promote osseointegration, macroscale coatings
have been applied to titanium implant surfaces via titanium plasma spray (TPS) as well as
hydroxyapatite (HA) coating or sintering for powder- or bead-based coatings [5–8]. These
coatings, however, are subjected to shear loads during surgical implantation, contact with
surgical tools, and eventually micromotion at the bone–implant interface in vivo [5–8].
These coatings may then separate from the substrate, generating third-body wear debris
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that increases mechanical wear of bearing surfaces. Additionally, local phagocytic cells encountering this debris may initiate a biologic cascade leading to periprosthetic osteolysis [9].
The body’s immune response to wear debris is dependent on particulate composition, concentration, and morphology and may result in periprosthetic joint infection, bone fracture,
catastrophic implant fracture, as well as osteoclastic bone resorption around the implant,
component loosening, and, ultimately, revision surgery [5,10,11].
Titanium nanotube (TiNT) surfaces, which are electrochemically etched from the
titanium implant substrate instead of applied as a coating, are an emerging technology that
may enhance osseointegration of orthopedic implants [12–17], although literature is scarce
regarding the in vivo immune response and toxicity to these nanostructured materials as
implantable devices [18,19]. Due to improved interfacial strength, decreased thickness, and
potential for more rapid osseointegration, TiNT surfaces may generate less third-body wear
particulate compared to current coating technologies; however, thorough characterization
of the immune and inflammatory response to new implantable materials is needed.
Two TiNT surface morphologies, termed aligned and trabecular, have been developed for orthopedic applications necessitating osseointegrative properties [17,20–22]. The
aligned TiNT morphology comprises arrays of vertically oriented nanotubes, while the
trabecular TiNT morphology exhibits a random surface resembling the three-dimensional
porous network of trabecular bone. In this study, local and systemic responses to aligned
and trabecular TiNT surfaces were assessed through in vitro cellular response on each
material as well as in vivo performance in a clinically relevant, rodent model of long-term
femoral intramedullary implant to simulate joint arthroplasty, including assessment of
longitudinal animal weights, remote organ weights, metal ion levels in remote organs and
whole blood, hematology, and nondecalcified histology [23,24]. Following on survivability
testing and finite element modeling indicating that compression and shear loading to the
TiNT surfaces were below yield failure strength, this study hypothesizes that TiNT surfaces will demonstrate equivalent local and systemic responses, equivalent to unmodified
titanium alloy substrate surfaces [22]. Further, we hypothesize that aligned and trabecular TiNT surfaces yield comparable in vitro and in vivo results, as both morphologies
provide additional surface area for cell attachment as well as resultant bony ongrowth and
ingrowth.
2. Materials and Methods
2.1. Implant Fabrication
Samples for in vitro and in vivo studies were fabricated with titanium alloy (Ti-6Al-4V
ELI) sheet and wire (wire: Custom Wire Technologies, Inc., Port Washington, WI, USA),
respectively, using a well-established electrochemical anodization process (Appendix A—
Supplemental Methods, Figure A1) [17,21]. Following the initial etching process, aligned
TiNT surfaces were then ultrasonicated in deionized (DI) water for 2 minutes; however,
trabecular TiNT surfaces received no additional treatment (Figure 1). Control samples
were rinsed with DI water and air-dried. On average, inside diameter (ID) of individual
nanotubes was 60 nm and 1 µm length on aligned TiNT surfaces. Similarly, trabecular TiNT
surfaces contained a 1 µm layer of 60 nm ID aligned nanotubes, on average, covered with
an additional 1 µm of over-etched nanotubes. The over-etched layer mimics the porous
structure and topography of trabecular bone.
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Figure
1. Aligned
titanium
nanotubes
(TiNT)
(A)trabecular
and trabecular
(B) surfaces.
Figure
1. Aligned
titanium
nanotubes
(TiNT)
(A) and
TiNTTiNT
(B) surfaces.
(A,B)(A,B)
Scale Scale
Bar: 1 µm.
Bar: 1 μm.
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were weighed weekly; at endpoint, hematologic, metal ion, and histologic analyses were
performed.
2.4. Surgical Procedure for Unilateral Intramedullary Implantation
Under an Institutional Animal Care and Use Committee (IACUC)-approved protocol,
14-week-old, female SD rats underwent unilateral femoral implants via retrograde insertion.
After anesthetization, rats were placed supine on a sterile, heated operating table with
the knee in maximum flexion. Following final sterile preparation, a lateral–patellar skin
incision allowed access to the distal femur. After drilling a shallow, pilot hole in the
intercondylar groove, a K-wire was inserted into the intramedullary canal to the greater
trochanter (proximal femur). Placement of the implant was confirmed via fluoroscopy.
The K-wire was then clipped and recessed at the insertion site, followed by closure of
arthrotomy and skin incisions with appropriate suture materials. Animals were then
recovered and allowed ad libitum activity under endpoint.
2.5. Postoperative Care and Health Assessments
All rats were evaluated daily for clinical signs of complications and overall health,
including pain level, activity level, and food/water consumption. Rats were weighed
preoperatively and weekly throughout the experiment. At endpoint, remote organs were
collected and weighed, as another assessment of animal health. A one-way ANOVA model
was used to compare longitudinal animal weights and endpoint organ weights between
treatment groups, with α = 0.05.
2.6. Hematologic Analysis
At endpoint, each anesthetized rat underwent antemortem cardiac puncture to collect
blood for hematologic analyses (CBC; complete blood count with differential) to quantify
the following thirteen parameters associated with either systemic inflammation/infection
or anemia status: white blood cell count (WBC), lymphocyte concentration (Lymph),
monocyte concentration (Mono), granulocyte concentration (Gran), hematocrit (HCT),
mean cell volume of red blood cells (MCV), red blood cell distribution width (RDWa),
hemoglobin concentration (Hgb), mean cell hemoglobin concentration (MCHC), mean cell
hemoglobin (MCH), red blood cell count (RBC), total platelet count (PLT), and mean and
platelet volume (MPV) (HemaTrue Hematology Analyzer, Heska, Loveland, CO, USA).
Blood was collected in vacutainer tubes with Ethylenediaminetetraacetic acid (EDTA) and
immediately processed. A one-way ANOVA model was used to compare hematologic
parameters between treatment groups, with α = 0.05.
2.7. Metal Ion Analysis of Whole Blood and Remote Organs
Inductively coupled plasma mass spectrometry (ICP-MS; HP 4500, Agilent Technologies, Santa Clara, CA, USA) was used to measure the titanium, aluminum, and vanadium concentrations in each remote organ and a whole blood sample from each animal
(Appendix A—Supplemental Methods). ICP-MS calibration was performed using both
ASTM standards of each target element as well as non-implanted samples of the rods
from each testing condition. At endpoint, remote organs (i.e., spleen, liver, lungs, kidneys,
brain) were harvested, weighed, and stored (4 ◦ C in ultra-low leachable sample tubes) until
analysis. Samples were analyzed in tandem with a laboratory reagent blank and duplicate
laboratory fortified blanks to quantify background metal levels as well as process accuracy
and precision, respectively. A one-way analysis of variance model was used to compare
metal ion levels between treatment groups, with α = 0.05.
2.8. Nondecalcified Histologic Analysis
At study endpoint, implanted femora were also harvested for nondecalcified histologic
analysis. Femora from each animal were stripped of soft tissues and 10% zinc-buffered
formalin for 96 h, followed by three rinses in phosphate buffered saline, and 70% ethanol
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At the 2- and 4-h timepoints, increased spreading was observed on TiNT surfaces
compared to control surfaces. Additional imaging via SEM showed differential cell mor-
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Subsequent analysis of cell morphology images yielded cell equivalent diameter and
Subsequent analysis of cell morphology images yielded cell equivalent diameter and
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ure 7). TiNT group (p = 0.039 and p = 0.019, respectively). There were no observed necrotic
or cytotoxic events observed within the marrow cavity of any of the animals (Figure 7).

Figure
of aluminum
aluminum(A),
(A),titanium
titanium(B),
(B),and
andvanadium
vanadium(C)
(C)ininremote
remote
organs
and
Figure 6.
6. Concentration
Concentration of
organs
and
whole
blood
for
each
group.
(WB
=
whole
blood).
For
aluminum
concentration,
significant
compariwhole blood for each group. (WB = whole blood). For aluminum concentration, significant comson:
trabecular
TiNTTiNT
vs. control,
p = 0.022.
parison:
trabecular
vs. control,
p = 0.022.

nomaterials 2021, 11, x FOR PEER REVIEW
Nanomaterials 2021, 11, 583

10 of 17

10 of 17

Table 3. Statistical comparisons (p-values) between implant groups with control of average histologic grade for three reTable*.3. Statistical comparisons (p-values) between implant groups with control of average histologic grade for three regions
gions of interest
of interest *.

Foreign Body
Group Group
Body
Giant/ ForeignGranulocyte
Neutrophil Neutrophil
Monocyte Monocyte
LymphocyteLymphocyte
ROI
Granulocyte
ROI(vs. Control)
(vs. Control)
Giant/Multinucleated
Multinucleated
TiNT 0.126
0.126 0.040
0.040
0.019
0.720
0.391
TrabecularTrabecular
TiNT
0.019
0.720
0.391
Distal
Distal
Aligned TiNT 0.287
0.287 0.476
0.476
0.345
0.720
0.260
Aligned TiNT
0.345
0.720
0.260
TrabecularTrabecular
TiNT
1.000
0.314
0.982
TiNT 0.142
0.142 0.603
0.603
1.000
0.314
0.982
Midshaft Midshaft
Aligned TiNT
0.039
0.682
0.019
0.736
0.260
Aligned TiNT
0.039
0.682
0.019
0.736
0.260
TrabecularTrabecular
TiNT
0.527
0.646
0.345
0.652
0.871
TiNT
0.527
0.646
0.345
0.652
0.871
Proximal Proximal
Aligned TiNT
0.939
0.219
0.345
0.747
0.314
Aligned TiNT
0.939
0.219
0.345
* Bolded p-values indicate significant results; ROI = region of interest.

0.747

0.314

* Bolded p-values indicate significant results; ROI = region of interest.
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In the in vivo study, there were several significant differences in body weight between
groups at two weeks during the experiment; however, the body weights recovered were
not an established trend, and no interventions were required at any time for weight loss.
At endpoint, remote organ masses were compared between groups, and these also showed
no significant difference. Despite increased concentrations of aluminum, titanium, and
vanadium in the aligned TiNT and trabecular TiNT wires versus control wires, only aluminum levels were significantly increased in the lungs of the rats implanted with trabecular
TiNT-etched wires compared to controls. No other organs or whole blood samples showed
significantly elevated metal levels, when the experimental groups were compared to control. A study of intraarticular injection of TiO2 nanoparticles (45 nm average diameter; 0.2,
2, 20 mg/kg TiO2 in suspension) into rat knee joints showed nanoparticle migration to
remote organs as well as pathologic changes in the heart, lung, liver, and knee at 7 days
post-injection [35,36]. Although our study showed metal ion concentration in remote
organs via ICP-MS and did not histologically assess remote organs, we theorize that the
amount of TiO2 particulate debris shed in the rat femora was likely less than 0.2 mg/kg.
At study endpoint, no hematologic markers of white and red blood cell function, which
would signal systemic inflammation-, infection-, or anemia-related complications, were
significantly elevated in the experimental groups compared to control. Histologic analysis
showed several significant differences in cell populations between the TiNT groups and
control, with less foreign body giant/multinucleated, eosinophil/basophil, and neutrophil
cell activity in TiNT-implanted femora than control. There were no significant differences
between monocyte and lymphocyte activity.
In in vitro and in vivo studies of vascular toxicity, Bayat et al. established that titanium
nanotubes with 30 nm diameter as well as ultra-small TiO2 nanoparticles (1−3 nm) were
not cytotoxic, and nanoparticles did not possess oxidative potential [37]. In vivo studies
in rat models have also shown that TiO2 nanoparticles are not genotoxic [38,39]. Neacsu
et al. showed that after seeding murine macrophages onto TiNT and unetched titanium
surfaces under pro-inflammatory and standard conditions, inflammatory activity related
to cytokine and chemokine gene expression, foreign body giant cell products, and nitric
oxide release all decreased on TiNT surfaces but not on unetched controls; therefore, the
authors suggested that the TiNT surfaces may regulate macrophage response, thereby
diminishing the overall inflammatory cascade [40]. Studies by Ostberg et al. and Latha
et al., using models of leukocyte-seeded TiNT surface and mixed lymphocyte reaction
(MLR), respectively, concurred with these findings [41,42]; specifically, Latha et al. showed
a 30–35% suppression of splenocyte proliferation of titanium nanotubes (H2 Ti3 O7 ) [42].
Assessing hemocompatbility, Smith et al. showed increased adsorption of blood serum
protein, platelet adhesion and activation, and clotting of whole blood as well as no evidence of monocyte activation and cytokine secretion on TiNT surfaces versus control [43].
Radizun et al. showed that aluminum nanoparticles, in concentrations up to 400 µg/mL,
have no significant toxic effect on mammalian cell viability, and Alshatwi et al. found
human MSC cytotoxicity via Al2 O3 nanoparticles at 40 µg/mL; in this study, aluminum
content in all specimens was substantially below this threshold (maximum aluminum
content within range of standard deviation; Figure 6: 4.24 µg/mL) [44,45]. In a clinical,
in vivo study, Swiatkowska et al. described titanium levels ranging between 2.20 and
2.56 µg/L in blood and plasma, measured via ICP-MS, in well-functioning unilateral hip
implants, indicating some level of titanium may be tolerable by patients, without eliciting
a whole-body response [46].
Study limitations included difficulties with staining TiNT surfaces, especially at timepoints greater than 4 h. Because of the nanotopography and voids, which were ideal for
cell attachment, stain penetration of the cells was complicated and incomplete. While three
naïve animals were included to assess background metal levels, inclusion of additional
animals may have been beneficial to further study and quantify these levels. Additionally, a full assessment of metal levels of animal food, bedding, enrichment materials, etc.
may have allowed further reduction and elimination of background aluminum, titanium,
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and vanadium levels in all animals [47,48]. Based on the results of this study, a full systematic characterization of this material’s biocompatibility and toxicity properties should
be conducted in accordance with applicable standards, such as ISO 10993-11 (Biological
Evaluation of Medical Devices—Part 11: Tests for Systemic Toxicity).
5. Conclusions
Previous studies have demonstrated the biocompatibility of TiNT surfaces and correspond with the findings of this study showing TiNT surfaces support cell attachment
and proliferation and do not initiate systemic effects in an in vivo model of intramedullary
implantation. The presented in vitro data demonstrated that cells cultured on bare TI6Al4V
surfaces were spindle shaped, while those cultured on TiNT surfaces demonstrated a more
rounded appearance, which may confer benefit with respect to in vivo bone formation.
In vivo data demonstrated that the accumulation of metal ions in filtering organs was
largely similar between the two morphologies of TiNT surfaces and control bare Ti6Al4V
surfaces, aside from an increased aluminum concentration in the lungs of rats with aligned
TiNT implants. This increased aluminum concentration in lung specimens was not associated with alterations in overall health of the animal or observed pathology. As such,
it can be concluded that at the time points studied, metal accumulation associated with
TiNT surfaces was similar to control surfaces, and no systemic or local complications were
observed in TiNT- or control-implanted animals.
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Appendix A. Supplemental Methods and Results
Appendix A.1. Titanium Nanotube-Etched Specimen Fabrication
Titanium nanotube-etched specimens were prepared for in vitro and in vivo experiments, based on previous methods developed and tested by our group [17,20–22]. Titanium
alloy (Ti-6Al-4V ELI) sheet (in vitro experiments) or wire (in vivo study) were polished
with 600 grit abrasive sheet and deionized (DI) water, then rinsed in DI water and air-dried.
All sample materials were cleaned with acetone just prior to etching, followed by air drying.
On wire samples, the trocar tip was coated to prevent nanotube formation on the site of
insertion. To etch, samples (sheet or wire) were suspended vertically toward one side of a
glass beaker and then connected as the anode to a variable DC power supply. Additionally,
in the beaker, a small diameter graphite rod was suspended, diametrically opposed to the
sample, and connected to ground (cathode). An electrolyte solution (98 vol.% ethylene
glycol, 2 vol.% deionized water, and 0.6 wt.% NH4F) was added to the beaker, with a
final volume just below the electrical connections to the sample and graphite. Before
adding NH4F to the electrolyte solution, it was first completely dissolved in DI water;
following this addition, the electrolyte solution was mixed to ensure all constituents were
fully combined. Then, the power supply was engaged (+60 VDC) and etching was allowed
to proceed for 40 minutes. After etching, the power supply was disengaged and sample(s)
were immediately removed from the beaker, followed by a 1-minute rinse under DI water
and air drying. After drying, the coating on each trocar tip was removed after etching
and sonication (aligned TiNT samples were sonicated for 2 min; trabecular TiNT samples
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Figure A1. Digital photographs showing the final appearance of 10 mm × 10 mm coupon samples
Figure A1. Digital photographs showing the final appearance of 10 mm × 10 mm coupon samples
(top) and Kirschner wires (bottom). TiNT-etched surfaces appear golden and smooth, compared to
(top) and Kirschner wires (bottom). TiNT-etched surfaces appear golden and smooth, compared to
unmodified control surfaces.
unmodified control surfaces.
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Figure A2. Imaging convention for each coupon in the experiment. Regions were chosen to reflect
Figure A2. Imaging convention for each coupon in the experiment. Regions were chosen to reflect
the corners (1–4), edges (5–8), central area (9–12), and absolute center (13) of each sample.
the corners (1–4), edges (5–8), central area (9–12), and absolute center (13) of each sample.
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Table A1. Average histologic grade for three regions of interest in each treatment group *.
ROI

Distal

Midshaft

Proximal

Group

Foreign Body
Giant/Multinucleated

Granulocyte

Neutrophil

Monocyte

Lymphocyte

Trabecular TiNT

0.8
(1.0)

0.1
(0.0)

0.7
(1.0)

0.8
(1.0)

1.1
(1.0)

Aligned
TiNT

0.7
(1.0)

0.2
(0.0)

1.1
(1.0)

0.8
(1.0)

1.1
(1.0)

Control

0.6
(0.5)

0.3
(0.0)

1.0
(1.0)

0.7
(1.0)

1.2
(1.0)

Trabecular TiNT

0.5
(0.5)

0.6
(1.0)

1.0
(1.0)

0.6
(1.0)

1.2
(1.0)

Aligned
TiNT

0.4
(0.0)

0.8
(1.0)

0.7
(1.0)

0.7
(1.0)

1.1
(1.0)

Control

0.8
(1.0)

0.7
(1.0)

1.0
(1.0)

0.7
(1.0)

1.2
(1.0)

Trabecular TiNT

0.8
(1.0)

0.6
(1.0)

0.9
(1.0)

0.8
(1.0)

1.4
(1.0)

Aligned
TiNT

0.7
(1.0)

0.4
(0.0)

1.1
(1.0)

0.9
(1.0)

1.3
(1.0)

Control

0.7
(1.0)

0.7
(1.0)

1.0
(1.0)

0.8
(1.0)

1.4
(1.0)

* Standard deviation listed in parentheses.
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